Cindy Womack, DNP, FNP-BC, CNRN

Certified Nurse Practitioner
Neurology
Accepting new patients
Call for an appointment
or

    About me

    Cindy Womack, DNP, FNP-BC, CNRN is a Nurse Practitioner in the Department of Neurology, specializing in Alzheimer's disease and dementia care. Prior to coming to SIU School of Medicine she maintained a private practice as a Geriatric Care Manager working with older adults and their families and advocating for quality eldercare in community settings. 

    Gender

    Female

    Education & training

    Positions
    Certified Nurse Practitioner
    Family Nurse Practicioner
    Neurology
    Board Certifications
    Certified Neuroscience Registered Nurse
    Family Nurse Practitioner
    Undergraduate Degree
    Southern Illinois University, Edwardsville, IL - Masters of Nursing

    Specialties

    Clinical locations

    Locations

    SIU Neurology Clinic

    751 N. Rutledge St. Springfield, IL 62702 Suite 3100
    Mon - Fri: 8:00 am-4:30 pm

    Hospital privileges

    • Memorial Health, Springfield IL

    Research

    Research Interests
    Alzheimer's Disease, Dementia, Caregiver stress/burden

    Clinical trials

    Trial
    Neurology

    Annovis - A Randomized, Double-Blind, Placebo-Controlled, Dose-ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer's Disease

    Active recruiting

    The purpose of this study is to assess the efficacy and safety of Buntanetap in participants with mild to moderate Alzheimer's Disease participants.

    Trial
    Neurology

    Annovis - A Randomized, Double-Blind, Placebo-Controlled, Dose-ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer's Disease

    Active recruiting

    The purpose of this study is to assess the efficacy and safety of Buntanetap in participants with mild to moderate Alzheimer's Disease participants.

    Trial
    Neurology

    Open-Label Extension of Studies ATH-1017-AD-0201 and ATH-1017-AD-0202 in Subjects with Mild to Moderate Alzheimer's Disease

    Active not recruiting

    ATH-1017-AD-203: The purpose of this study is to determine the safety and tolerability of ATH-1017 in patients with mild to moderate Alzheimer's disease.

    Trial
    Neurology

    Lilly: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

    Active not recruiting

    I5T-MC-AACI:  The purpose of this study is to assess the effect of donanemab versus placebo on clinical regression in participants with early symptomatic Alzheimer's disease with presence of low-medium tau pathology.

    Trial
    Neurology

    Lilly: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

    Active not recruiting

    I5T-MC-AACI:  The purpose of this study is to assess the effect of donanemab versus placebo on clinical regression in participants with early symptomatic Alzheimer's disease with presence of low-medium tau pathology.

    Related articles

    Bain Scan

    SIU School of Medicine receives major gift for Alzheimer's research

    A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial